Lb Pharmaceuticals (LBRX) Amortizatization of Intangibles (2024 - 2026)
Lb Pharmaceuticals (LBRX) recorded quarterly Amortizatization of Intangibles of -$17000.0 in Q1 2026, little changed quarter-over-quarter from -$17000.0 in Q4 2025, and down 241.67% on a YoY basis from $12000.0 in Q1 2025.
Lb Pharmaceuticals (LBRX) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$17000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 241.67% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at $39000.0 (changed N/A YoY), while the FY2025 annual figure was -$261000.0, down 867.65% from the prior year.
- Amortizatization of Intangibles was -$17000.0 for Q1 2026 at Lb Pharmaceuticals, roughly flat from -$17000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $61000.0 in Q4 2024 to a low of -$17000.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $9750.0 across 3 years, with a median of -$2500.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles tumbled 127.87% in 2025, then tumbled 241.67% in 2026.
- A 3-year view of Amortizatization of Intangibles shows it stood at $61000.0 in 2024, then sank by 127.87% to -$17000.0 in 2025, then changed by 0.0% to -$17000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at -$17000.0 (Q1 2026), -$17000.0 (Q4 2025), and $12000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lb Pharmaceuticals | 843.30 Mn | 843.30 Mn | - | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2024 | 61,000.00 |